| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 15.062 | 60.219 | 59.880 | 60.060 | 39.473 |
| Total Income - EUR | - | - | - | - | - | 15.062 | 60.219 | 59.880 | 60.060 | 39.473 |
| Total Expenses - EUR | - | - | - | - | - | 12.011 | 54.635 | 55.249 | 67.602 | 45.113 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 3.051 | 5.584 | 4.631 | -7.542 | -5.639 |
| Net Profit/Loss - EUR | - | - | - | - | - | 2.803 | 4.979 | 4.030 | -8.143 | -5.639 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 2 | 1 |
Check the financial reports for the company - Aly Pharma Vet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 221 | 4.700 | 6.989 | 8.423 | 6.661 |
| Current Assets | - | - | - | - | - | 4.378 | 2.780 | 16.719 | 16.712 | 7.733 |
| Inventories | - | - | - | - | - | 1.738 | 1.255 | 14.278 | 14.761 | 0 |
| Receivables | - | - | - | - | - | 41 | 40 | 1.043 | 37 | 858 |
| Cash | - | - | - | - | - | 2.599 | 1.485 | 1.397 | 1.914 | 6.875 |
| Shareholders Funds | - | - | - | - | - | 2.845 | 5.019 | 4.071 | -4.084 | -9.701 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.755 | 2.461 | 19.637 | 29.219 | 24.095 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Aly Pharma Vet S.r.l.